These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28161130)

  • 1. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
    Tamargo J; Rosano GM; Delpón E; Ruilope L; López-Sendón J
    Int J Cardiol; 2017 Apr; 233():1-11. PubMed ID: 28161130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of phase II acute heart failure syndromes clinical trials.
    Pang PS; Gheorghiade M
    Heart Fail Clin; 2011 Oct; 7(4):441-50. PubMed ID: 21925427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase.
    Gheorghiade M; Pang PS; O'Connor CM; Prasad K; McMurray J; Teerlink JR; Fiuzat M; Sabbah H; Komajda M
    Am Heart J; 2011 Feb; 161(2):224-32. PubMed ID: 21315202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research.
    Cotter G; Cohen-Solal A; Davison BA; Mebazaa A
    Eur J Heart Fail; 2017 Nov; 19(11):1355-1357. PubMed ID: 28836728
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons learned from clinical trials in acute heart failure: phase 3 drug trials.
    O'Connor CM; Fiuzat M
    Heart Fail Clin; 2011 Oct; 7(4):451-6. PubMed ID: 21925428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
    Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A
    Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New investigational drugs for the management of acute heart failure syndromes.
    Tamargo J; Amorós I; Barana A; Caballero R; Delpón E
    Curr Med Chem; 2010; 17(4):363-90. PubMed ID: 20015042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR
    Am J Cardiol; 2005 Sep; 96(6A):59G-67G. PubMed ID: 16181824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of emerging pharmacologic agents for acute heart failure syndromes.
    De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M
    Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials.
    De Luca L; Fonarow GC; Mebazaa A; Shin DD; Collins SP; Swedberg K; Gheorghiade M
    Acute Card Care; 2007; 9(1):10-21. PubMed ID: 17453534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End points for clinical trials in acute heart failure syndromes.
    Allen LA; Hernandez AF; O'Connor CM; Felker GM
    J Am Coll Cardiol; 2009 Jun; 53(24):2248-58. PubMed ID: 19520247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of acute heart failure.
    Milo-Cotter O; Bettari L; Kleijn L; Bugatti S; Lombardi C; Rund M; Metra M; Voors AA; Cotter G; Kaluski E; Weatherley BD
    Panminerva Med; 2010 Mar; 52(1):53-66. PubMed ID: 20228726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
    Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
    J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serelaxin and acute heart failure.
    Tietjens J; Teerlink JR
    Heart; 2016 Jan; 102(2):95-9. PubMed ID: 26603680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial.
    Collins SP; Lindsell CJ; Pang PS; Storrow AB; Peacock WF; Levy P; Rahbar MH; Del Junco D; Gheorghiade M; Berry DA
    Am Heart J; 2012 Aug; 164(2):138-45. PubMed ID: 22877798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure.
    Krum H; Abraham WT
    Lancet; 2009 Mar; 373(9667):941-55. PubMed ID: 19286093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M; De Luca L; Massie MB; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extrapolation of results from clinical trials to heart failure patients hospitalized in Internal Medicine].
    Conde Martel A
    Med Clin (Barc); 2014 May; 142(10):463-7. PubMed ID: 24022030
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging drug therapies for the management of acute decompensated heart failure.
    Tunuguntla A
    Tenn Med; 2007 Nov; 100(11):33-7. PubMed ID: 18072692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale for an acute heart failure syndromes clinical trials network.
    Collins SP; Levy PD; Lindsell CJ; Pang PS; Storrow AB; Miller CD; Naftilan AJ; Thohan V; Abraham WT; Hiestand B; Filippatos G; Diercks DB; Hollander J; Nowak R; Peacock WF; Gheorghiade M
    J Card Fail; 2009 Aug; 15(6):467-74. PubMed ID: 19643356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.